Background: The aims of this study were to determine (1) the prevalence of atopic dermatitis (AD) in Seoul, Korea, and (2) the influence of environmental and genetic factors on disease risk. Methods: A questionnaire survey was conducted in 5,036 primary school children and 4,607 middle school children in 2008. For each child, a modified version of the International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire and a questionnaire assessing exposure to environmental variables were completed. Results: In primary school children, the lifetime prevalence of itchy eczema was 24.3%, the 12-month prevalence of itchy flexural eczema was 18.0%, the lifetime prevalence of AD diagnosis was 31.3%, and the 12-month prevalence of AD treatment was 14.5%. In middle school children, the corresponding rates were 16.0, 10.8, 22.1, and 8.3%, respectively. These rates are significantly higher than those reported in similar studies conducted in 1995 and 2000. In both primary and middle school children, a parental history of allergic disease and a history of having moved into a newly built house before 1 year of age were independently associated with a risk for current AD. For current AD, the prevalence odds ratio was higher in the subgroup with both a genetic and a specific environmental risk factor than in the subgroup with no risk factor or subgroups with only one risk factor. Conclusions: The prevalence of AD in primary and middle school children in Seoul has increased. Its development may be influenced by gene-environment interactions, particularly before 1 year of age.

Keywords:
Atopic dermatitis, Gene-environment interaction, Prevalence, Risk factor
1.
Spergel JM, Paller AS: Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003;112:S118–S127.
2.
Wüthrich B: Clinical aspects, epidemiology, and prognosis of atopic dermatitis. Ann Allergy Asthma Immunol 1999;83:464–470.
3.
Barnetson RS, Rogers M: Childhood atopic eczema. BMJ 2002;324:1376–1379.
4.
Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998;351:1225–1232.
5.
Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK, Williams H: Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 2006;368:733–743.
6.
Devenny A, Wassall H, Ninan T, Omran M, Khan SD, Russell G: Respiratory symptoms and atopy in children in Aberdeen: questionnaire studies of a defined school population repeated over 35 years. BMJ 2004;329:489–490.
7.
Stensen L, Thomsen SF, Backer V: Change in prevalence of atopic dermatitis between 1986 and 2001 among children. Allergy Asthma Proc 2008;29:392–396.
8.
Yura A, Shimizu T: Trends in the prevalence of atopic dermatitis in school children: Longitudinal study in Osaka Prefecture, Japan, from 1985 to 1997. Br J Dermatol 2001;145:966–973.
9.
Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, Mitchell EA, Pearce N, Sibbald B, Stewart AW, et al: International study of asthma and allergies in childhood (ISAAC): Rationale and methods. Eur Respir J 1995;8:483–491.
10.
Lee SI, Shin MH, Lee HB, Lee JS, Son BK, Koh YY, Kim KE, Ahn YO: Prevalences of symptoms of asthma and other allergic diseases in Korean children: a nationwide questionnaire survey. J Korean Med Sci 2001;16:155–164.
11.
Oh JW, Pyun BY, Choung JT, Ahn KM, Kim CH, Song SW, Son JA, Lee SY, Lee SI: Epidemiological change of atopic dermatitis and food allergy in school-aged children in Korea between 1995 and 2000. J Korean Med Sci 2004;19:716–723.
12.
Martino DJ, Prescott SL: Silent mysteries: Epigenetic paradigms could hold the key to conquering the epidemic of allergy and immune disease. Allergy 2010;65:7–15.
13.
Waterland RA, Michels KB: Epigenetic epidemiology of the developmental origins hypothesis. Annu Rev Nutr 2007;27:363–388.
14.
Hong SJ AK, Lee SY, Kim KE: The prevalences of asthma and allergic diseases in Korean children. Pediatr Allergy Respir Dis 2008;18:15–25.
15.
Batlles Garrido J, Torres-Borrego J, Bonillo Perales A, Rubi Ruiz T, Gonzalez Jimenez Y, Momblan De Cabo J, Aguirre Rodriguez J, Jimenez Liria R, Losilla Maldonado A, Daza Torres M: Prevalence and factors linked to atopic eczema in 10- and 11-year-old schoolchildren. ISAAC 2 in Almeria, Spain. Allergol Immunopathol (Madr) 2010;38:174–180.
16.
Di Domenicantonio R, De Sario M, Sammarro S, Compagnucci P, Forastiere F, Pistelli R, Serra MG, Corbo G, Agabiti N, Perucci CA: Asthma and allergies in childhood in Rome: Italian contribution to the ISAAC II (in Italian). Epidemiol Prev 2003;27:226–233.
17.
Dold S, Wjst M, von Mutius E, Reitmeir P, Stiepel E: Genetic risk for asthma, allergic rhinitis, and atopic dermatitis. Arch Dis Child 1992;67:1018–1022.
18.
Kjellman NI: Prediction and prevention of atopic allergy. Allergy 1998;53:67–71.
19.
Diepgen TL, Blettner M: Analysis of familial aggregation of atopic eczema and other atopic diseases by odds ratio regression models. J Invest Dermatol 1996;106:977–981.
20.
Guo SW: Familial aggregation of environmental risk factors and familial aggregation of disease. Am J Epidemiol 2000;151:1121–1131.
21.
Jaakkola JJ, Hwang BF, Jaakkola N: Home dampness and molds, parental atopy, and asthma in childhood: a six-year population-based cohort study. Environ Health Perspect 2005;113:357–361.
22.
Sahakian NM, Park JH, Cox-Ganser JM: Dampness and mold in the indoor environment: Implications for asthma. Immunol Allergy Clin North Am 2008;28:485–505, vii.
23.
Schafer T, Stieger B, Polzius R, Krauspe A: Atopic eczema and indoor climate: Results from the children from Lübeck allergy and environment study (KLAUS). Allergy 2008;63:244–246.
24.
McNally NJ, Williams HC, Phillips DR: Atopic eczema and the home environment. Br J Dermatol 2001;145:730–736.
25.
Miyake Y, Ohya Y, Tanaka K, Yokoyama T, Sasaki S, Fukushima W, Ohfuji S, Saito K, Kiyohara C, Hirota Y: Home environment and suspected atopic eczema in Japanese infants: The Osaka Maternal and Child Health Study. Pediatr Allergy Immunol 2007;18:425–432.
26.
Ibargoyen-Roteta N, Aguinaga-Ontoso I, Fernandez-Benitez M, Marin-Fernandez B, Guillen-Grima F, Serrano-Monzo I, Hermoso-de-Mendoza J, Brun-Sandiumetge C, Ferrer-Nadal A, Irujo-Andueza A: Role of the home environment in rhinoconjunctivitis and eczema in schoolchildren in Pamplona, Spain. J Investig Allergol Clin Immunol 2007;17:137–144.
27.
Apfelbacher CJ, Diepgen TL, Schmitt J: Determinants of eczema: population-based cross-sectional study in Germany. Allergy 2011;66:206–213.
28.
Sakaguchi J, Akabayashi S: Field survey of indoor air quality in detached houses in Niigata Prefecture. Indoor Air 2003;13(suppl 6):42–49.
29.
Takigawa T, Wang BL, Saijo Y, Morimoto K, Nakayama K, Tanaka M, Shibata E, Yoshimura T, Chikara H, Ogino K, Kishi R: Relationship between indoor chemical concentrations and subjective symptoms associated with sick building syndrome in newly built houses in Japan. Int Arch Occup Environ Health 2010;83:225–235.
30.
Mendell MJ: Indoor residential chemical emissions as risk factors for respiratory and allergic effects in children: a review. Indoor Air 2007;17:259–277.
31.
Bakke JV, Wieslander G, Norback D, Moen BE: Atopy, symptoms and indoor environmental perceptions, tear film stability, nasal patency and lavage biomarkers in university staff. Int Arch Occup Environ Health 2008;81:861–872.
32.
Stenberg B, Eriksson N, Hoog J, Sundell J, Wall S: The sick building syndrome (SBS) in office workers. A case-referent study of personal, psychosocial and building-related risk indicators. Int J Epidemiol 1994;23:1190–1197.
33.
Halmerbauer G, Gartner C, Schier M, Arshad H, Dean T, Koller DY, Karmaus W, Kuehr J, Forster J, Urbanek R, Frischer T: Study on the prevention of allergy in children in Europe (SPACE): Allergic sensitization in children at 1 year of age in a controlled trial of allergen avoidance from birth. Pediatr Allergy Immunol 2002;13(suppl 15):47–54.
34.
Custovic A, Simpson BM, Simpson A, Hallam C, Craven M, Brutsche M, Woodcock A: Manchester asthma and allergy study: Low-allergen environment can be achieved and maintained during pregnancy and in early life. J Allergy Clin Immunol 2000;105:252–258.
35.
Dietert RR, Zelikoff JT: Early-life environment, developmental immunotoxicology, and the risk of pediatric allergic disease including asthma. Birth Defects Res B Dev Reprod Toxicol 2008;83:547–560.
36.
Hoffjan S, Nicolae D, Ostrovnaya I, Roberg K, Evans M, Mirel DB, Steiner L, Walker K, Shult P, Gangnon RE, Gern JE, Martinez FD, Lemanske RF, Ober C: Gene-environment interaction effects on the development of immune responses in the 1st year of life. Am J Hum Genet 2005;76:696–704.
37.
Ciaccio CE, Portnoy JM: Strategies for primary prevention of atopy in children. Curr Allergy Asthma Rep 2008;8:493–499.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.